The pneumatic nebulizers market is projected to gain significant traction by 2027 on account of increasing chronic respiratory ailments across the globe. Additionally, the growing geriatric population is expected to further support market growth through the forecast timeline.

The COVID-19 infection is known to cause prolonged respiratory problems in some patients, particularly those with an existing underlying health condition, such as asthma, diabetes, and cardiovascular disease, among others. As a result, a surge in the global demand for nebulizers among infected patients has bolstered industry expansion during the pandemic.

Notably, prominent industry players are employing various lucrative business strategies to capitalize on emerging market trends through acquisitions, partnerships, and product launches, among others, which has positively impacted the overall market landscape. For instance, in September 2020, Aerogen, a global leader in aerosol drug delivery, established a new collaboration with C??RAM, the SFI Research Center at NUI Galway.

The partnership was intended to improve the administration of heparin into the lungs of patients suffering from COVID-19-induced acute respiratory distress syndrome (ARDS) using the Aerogen Solo nebulizer. Through the collaboration, Aerogen sought to provide enhanced aerosol drug delivery therapy for the globally expanding patient base infected with the novel coronavirus.

To cite another instance, in May 2019, Salter Labs, a leading healthcare company specializing in respiratory care, announced the acquisition of the CapnoVue line of capnography products from Monitor Mask, a company working to make face mask capnography more effective. CapnoVue aims to improve patient safety by allowing more doctors to use end-tidal CO2 monitoring through a face mask.

Face mask capnography is becoming increasingly popular as clinicians seek to supply more oxygen to patients during sedative procedures, especially to those who are at a higher risk. With the addition of CapnoVue, the Salter Team wanted to provide doctors with the greatest airway management product line in the industry as well as the most cutting-edge solutions for patient safety.

For comprehensive analysis, the pneumatic nebulizers market has been bifurcated on the basis of product and region. With respect to product, the market has further been categorized into breath actuated and vented. The vented product segment is expected to garner substantial gains over the estimated period, registering a valuation of more than USD 300.4 million by the end of 2027.

From the regional point of view, the Latin America pneumatic nebulizers market accounted for a market share of around 4.6% in 2020 and is set to grow at a steady pace over 2021-2027. Meanwhile, the Middle East & Africa pneumatic nebulizers market is anticipated to expand at a CAGR of approximately 6.0% over the assessment timeframe to reach a notable valuation by the end of the review period.